Welcome to our dedicated page for Airsculpt Technologies news (Ticker: AIRS), a resource for investors and traders seeking the latest updates and insights on Airsculpt Technologies stock.
AirSculpt Technologies Inc. (AIRS) delivers innovative body contouring solutions through its patented AirSculpt® technology, combining medical precision with minimally invasive techniques. This news hub provides investors and industry observers with essential updates on corporate developments, clinical advancements, and market positioning.
Access official press releases covering earnings reports, facility expansions, technology patents, and partnership announcements. Our curated collection enables efficient tracking of operational milestones in the competitive medical aesthetics sector.
Key coverage areas include regulatory filings, procedure innovation updates, executive leadership changes, and strategic growth initiatives. All content is sourced directly from company communications to ensure accuracy and timeliness.
Bookmark this page for streamlined monitoring of AIRS's progress in advancing body contouring technologies and expanding its North American clinic network. Verify publication dates for the latest developments in this dynamic healthcare segment.
AirSculpt Technologies (NASDAQ: AIRS) has expanded its operations with the opening of two new centers in Austin, Texas, and Orange County, California, bringing its total to 24 locations across the U.S. and Canada. The new centers aim to meet the increasing demand for AirSculpt's patented body contouring procedures, which are known for their minimal invasiveness and quick recovery times. Over 40,000 procedures have already been performed, indicating a strong market presence. CEO Todd Magazine expressed enthusiasm about the expansion, highlighting the growing consumer interest in their premium services.
AirSculpt Technologies, Inc. (NASDAQ:AIRS) announced its fourth quarter and full year 2022 results, highlighting significant growth in case volume and revenue.
Fourth quarter case volume increased by 15.7% year-over-year, reaching 3,337, while revenue rose by 8.4% to $40.7 million. For the full year, case volume grew 18.2% to 13,063 and revenue surged 26.6% to $168.8 million. Despite a diluted loss per share of $(0.26), the company reported an adjusted net income of $0.37 per share. Looking ahead, AirSculpt expects revenues between $187 million and $192 million for 2023, driven by the opening of five new centers.
FAQ
What is the current stock price of Airsculpt Technologies (AIRS)?
What is the market cap of Airsculpt Technologies (AIRS)?
